Skip to content

US · PFSA

Profusa, Inc. Common Stock

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Medical - Devices
Headquarters
Berkeley, CA 94710

Price · as of 2026-09-04

$2.72

Market cap 4.15M

Price history

Weekly OHLC price history for PFSA, USD per share
WeekOpenHighLowCloseVolume
Jul 7, 2025 – Jul 11, 2025$30,075.00$41,250.00$18,150.00$18,750.00
Jul 14, 2025 – Jul 18, 2025$16,650.00$18,000.00$7,875.00$8,250.000
Jul 21, 2025 – Jul 25, 2025$9,525.00$9,975.00$4,883.00$5,100.000
Jul 28, 2025 – Aug 1, 2025$5,595.00$16,650.00$3,825.00$4,403.000
Aug 4, 2025 – Aug 8, 2025$4,350.00$4,598.00$3,420.00$3,495.000
Aug 11, 2025 – Aug 15, 2025$3,750.00$4,748.00$3,525.00$3,745.000
Aug 18, 2025 – Aug 22, 2025$3,930.00$4,313.00$3,473.00$3,750.000
Aug 25, 2025 – Aug 29, 2025$3,659.00$5,190.00$2,878.00$3,075.000
Sep 1, 2025 – Sep 5, 2025$3,033.00$3,075.00$2,267.00$2,298.000
Sep 8, 2025 – Sep 12, 2025$2,394.00$4,500.00$1,988.00$2,951.000
Sep 15, 2025 – Sep 19, 2025$3,071.00$3,236.00$2,318.00$2,496.000
Sep 22, 2025 – Sep 26, 2025$2,441.00$2,550.00$2,175.00$2,299.000
Sep 29, 2025 – Oct 3, 2025$2,250.00$2,486.00$2,167.00$2,484.000
Oct 6, 2025 – Oct 10, 2025$2,484.00$2,925.00$2,362.00$2,461.000
Oct 13, 2025 – Oct 17, 2025$2,625.00$2,999.00$2,108.00$2,230.000
Oct 20, 2025 – Oct 24, 2025$2,362.00$2,471.00$1,949.00$2,175.000
Oct 27, 2025 – Oct 31, 2025$2,213.00$3,000.00$1,634.00$1,794.000
Nov 3, 2025 – Nov 7, 2025$1,676.00$1,725.00$869.00$1,364.000
Nov 10, 2025 – Nov 14, 2025$1,391.00$1,594.00$1,354.00$1,457.000
Nov 17, 2025 – Nov 21, 2025$1,440.00$1,470.00$983.00$1,038.000
Nov 24, 2025 – Nov 28, 2025$1,076.00$1,327.00$1,021.00$1,270.000
Dec 1, 2025 – Dec 5, 2025$1,313.00$1,517.00$1,154.00$1,327.000
Dec 8, 2025 – Dec 12, 2025$1,275.00$1,510.00$1,133.00$1,144.000
Dec 15, 2025 – Dec 19, 2025$1,178.00$1,182.00$713.00$881.000
Dec 22, 2025 – Dec 26, 2025$805.00$810.00$536.00$539.000
Dec 29, 2025 – Jan 2, 2026$536.00$1,271.00$488.00$750.000
Jan 5, 2026 – Jan 9, 2026$739.00$821.00$604.00$707.000
Jan 12, 2026 – Jan 16, 2026$690.00$985.00$600.00$769.000
Jan 19, 2026 – Jan 23, 2026$712.00$907.00$683.00$855.000
Jan 26, 2026 – Jan 30, 2026$818.00$822.00$614.00$695.000
Feb 2, 2026 – Feb 6, 2026$733.00$733.00$388.00$437.000
Feb 9, 2026 – Feb 13, 2026$414.00$422.00$188.00$201.000
Feb 16, 2026 – Feb 20, 2026$194.00$196.00$137.00$144.000
Feb 23, 2026 – Feb 27, 2026$143.00$144.00$103.00$104.000
Mar 2, 2026 – Mar 6, 2026$87.00$104.00$84.84$89.040
Mar 9, 2026 – Mar 13, 2026$90.00$94.00$82.00$91.720
Mar 16, 2026 – Mar 20, 2026$90.00$93.00$41.00$52.720
Mar 23, 2026 – Mar 27, 2026$52.72$53.76$43.80$47.480
Mar 30, 2026 – Apr 2, 2026$48.56$90.00$43.76$75.800
Apr 6, 2026 – Apr 10, 2026$192.00$225.00$84.00$86.520
Apr 13, 2026 – Apr 17, 2026$83.00$84.60$62.00$69.200
Apr 20, 2026 – Apr 24, 2026$69.92$69.92$56.00$57.720
Apr 27, 2026 – May 1, 2026$57.72$64.76$46.24$56.160
May 4, 2026 – May 8, 2026$55.04$59.20$43.56$51.600
May 11, 2026 – May 15, 2026$50.56$51.56$40.32$44.520
May 18, 2026 – May 22, 2026$44.32$44.80$36.12$37.600
May 25, 2026 – May 29, 2026$38.76$39.00$34.32$35.440
Jun 1, 2026 – Jun 5, 2026$36.52$36.52$26.28$26.840
Jun 8, 2026 – Jun 12, 2026$28.00$29.52$21.60$22.440
Jun 15, 2026 – Jun 18, 2026$24.64$26.40$17.04$18.080
Jun 22, 2026 – Jun 26, 2026$16.48$17.60$10.56$11.440
Jun 29, 2026 – Jul 2, 2026$11.36$13.20$8.00$9.360
Jul 6, 2026 – Jul 10, 2026$9.32$12.04$7.72$8.480
Jul 13, 2026 – Jul 17, 2026$8.12$9.60$6.76$6.920
Jul 20, 2026 – Jul 24, 2026$7.08$9.80$6.40$6.840
Jul 27, 2026 – Jul 31, 2026$5.12$5.52$3.44$4.240
Aug 3, 2026 – Aug 7, 2026$3.92$4.12$3.52$3.850
Aug 10, 2026 – Aug 14, 2026$3.83$4.00$3.22$3.600
Aug 17, 2026 – Aug 21, 2026$4.08$28.32$3.75$5.460
Aug 24, 2026 – Aug 28, 2026$5.26$5.69$2.74$2.930
Aug 31, 2026 – Sep 4, 2026$3.10$3.55$2.49$2.720

Valuation

MetricValueUpside
IC Value
P/E-0.21
P/B-0.29
P/S
EV/EBITDA-0.67
PEG
P/TBV-0.29

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for PFSA, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025$22.92

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Profusa, Inc. Common Stock

        Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.

        CEO
        Ben Chung-Bin Hwang
        Employees
        2
        Beta
        0.44

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for PFSA: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        PFSAProfusa, Inc. Common Stoc…$0.964.15M-0.21-0.29-0.67-0.290.00%0.00%0.00%49.12%31.18%-1046.23%-0.56-2.600.170.08-0.42-70.04%686.83%-211.82%-0.7338.34%0.00%0.00%455.78%-1.57-1.27-76.91
        ACXPAcurx Pharmaceuticals, In…$1.472.33M0.001.10947.751.100.00%0.00%0.00%-270799.68%0.21%-137978.60%0.003.183121.16948.48-69.76%65271.28%-116706.36%-2803.78179.72%0.00%0.00%129852.77%933.061.11-14.92
        ADILAdial Pharmaceuticals, In…$4.053.89M-0.160.250.570.250.00%0.00%0.00%-170.73%5431.38%-134.72%0.004.424.240.74-32.79%-6.21%-495.42%-4.654521.31%0.00%0.00%162.58%0.590.70-20.95
        APREAprea Therapeutics, Inc.$0.624.03M$1.59+156%-0.380.390.780.390.00%0.00%0.00%-79.37%464.34%-63.14%0.005.635.281.16-17.87%-100.00%-4.99%-267.94%-4.66452.43%0.00%0.00%0.00%0.740.76-30.27
        BCDABioCardia, Inc.$0.9510.39M$1.05+11%-1.029.39-0.839.390.00%0.00%0.00%-950.12%999.76%-230.57%0.591.121.030.25-57.59%-100.00%-7.33%-88.60%-3.06898.91%0.00%0.00%6.52%-0.78-0.86-74.95
        BFRIBiofrontera Inc.$1.2415.88M$33.82+2,627%-0.840.840.21-0.941.1378.65%-21.94%-25.26%-141.30%-133.63%-41.59%0.59-20.241.521.150.03-72.05%11.80%29.36%-151.00%-1.12-195.19%0.00%0.00%0.00%-0.94-0.640.21-5.31
        HCWBHCW Biologics Inc.$3.431.19M$109.94+3,105%-0.140.3919.96-1.05-0.010.3920.00%-20757.65%-14677.14%397.45%-228.13%-29.07%2.46-9.000.110.09-0.861280.52%-97.89%-7.57%-1237.20%-0.64-271.38%0.00%0.00%384.44%-0.53-0.44109.51-8.60
        LUCYLucyd, Inc$0.714.5M$490.74+68,680%-0.590.491.680.270.5321.32%-319.16%-285.20%-83.60%-411.77%-75.99%0.009.036.680.87-63.39%62.65%7.40%-168.31%-6.96-364.76%0.00%0.00%86.83%0.240.27-0.77-3.47
        SBFMSunshine Biopharma, Inc.$1.333.16M$880.34+66,091%-0.770.200.130.660.2232.84%-12.34%-16.46%-25.68%-30.37%-19.71%0.044.171.951.48-80.33%4.11%-62.93%-120.40%-0.83-37.33%0.00%0.00%0.00%0.830.68-0.10-1.57

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.72) − 1 = — (IC, example).